This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Xia, L. Articles by Flores-Rozas, H. Search for Related Content PubMed PubMed Citation Articles by Xia, L. Articles by Flores-Rozas, H.

Identification of Genes Required for Protection from Doxorubicin by a Genome-Wide Screen in Saccharomyces cerevisiae

¹ Institute of Molecular Medicine and Genetics, ² Center for Molecular Chaperone/Radiobiology and Cancer Virology Group, and ³ Department of Medicine, Medical College of Georgia, Augusta, Georgia

Requests for reprints: Hernan Flores-Rozas, Medical College of Georgia, 1120 15th Street, CB-2803, Augusta, GA 30912. Phone: 706-721-1371; Fax: 706-721-8752; E-mail: hfloresrozas{at}mail.mcg.edu.

Anthracyclines are chemotherapeutic agents commonly used to treat a broad range of malignancies. Although effective, these drugs present serious complications, most notably cardiotoxicity. To determine the mechanisms that mediate cytoprotection from doxorubicin, we have screened the collection of Saccharomyces cerevisiae haploid gene deletion mutants. We have identified 71 deletion strains that display varying degrees of hypersensitivity to doxorubicin at a concentration that does not significantly reduce the viability of wild-type cells. Complementation of the doxorubicin-sensitive phenotype of the deletion strains with the wild-type genes proves that the sensitivity of the strain to doxorubicin is due to the gene deletion. The genes that mediate cytoprotection from doxorubicin belong to multiple pathways including DNA repair, RNA metabolism, chromatin remodeling, amino acid metabolism, and heat shock response. In addition, proteins with mitochondrial, osmosensing, vacuolar, and ribosomal functions are also required for protection from doxorubicin. We tested the sensitivity of the deletion strains to other cytotoxic agents, which resulted in different drug-specific sensitive groups. Most of the identified genes have mammalian homologues that participate in conserved pathways. Our data may prove useful to develop strategies aimed at sensitizing tumor cells to doxorubicin as well as protecting cardiac cells from its cytotoxic effects. [Cancer Res 2007;67(23):11411–8]

This article has been cited by other articles:

				M. Lis, J. R. Fuss, and L. A. Bobek Exploring the Mode of Action of Antimicrobial Peptide MUC7 12-Mer by Fitness Profiling of Saccharomyces cerevisiae Genomewide Mutant Collection Antimicrob. Agents Chemother., September 1, 2009; 53(9): 3762 - 3769. [Abstract] [Full Text] [PDF]